https://www.nasdaq.com/press-release/biodesix-strengthens-financial-position-with-equity-issuance-and-amendment-to-term
https://www.nasdaq.com/press-release/biodesix-announces-appointment-of-successful-innovator-and-scientific-professional
https://www.nasdaq.com/press-release/biodesix-partners-with-spesana-to-streamline-digital-access-to-molecular-diagnostics
https://www.nasdaq.com/press-release/biodesix-announces-publication-highlighting-interim-data-from-the-insight-study
https://www.nasdaq.com/press-release/biodesix-announces-third-quarter-2021-results-and-highlights-2021-11-15
https://www.nasdaq.com/press-release/biodesix-to-present-data-supporting-proteomic-based-immunotherapy-diagnostic-tests
https://www.nasdaq.com/press-release/biodesix-to-present-at-the-canaccord-genuity-virtual-medtech-diagnostics-and-digital
https://www.nasdaq.com/press-release/biodesix-to-report-third-quarter-2021-financial-results-on-november-15-2021-2021-11
https://www.nasdaq.com/press-release/biodesix-announces-new-data-on-nodify-lungr-nodule-risk-assessment-testing-at-the
https://www.nasdaq.com/press-release/biodesix-announces-abstracts-presented-during-the-iaslc-2021-world-conference-on-lung
https://www.nasdaq.com/press-release/biodesix-to-present-at-the-morgan-stanley-virtual-19th-annual-global-healthcare
https://www.nasdaq.com/press-release/biodesix-desoto-laboratory-receives-both-iso-13485%3a2016-certification-and
https://www.nasdaq.com/press-release/biodesix-announces-second-quarter-2021-results-and-highlights-2021-08-10
https://www.nasdaq.com/press-release/biodesix-to-present-at-the-canaccord-genuity-41st-annual-growth-conference-2021-08-02
https://www.nasdaq.com/press-release/biodesix-to-report-second-quarter-2021-financial-results-on-august-10-2021-2021-07-27
https://www.nasdaq.com/press-release/biodesix-announces-presentation-on-novel-proteomic-techniques-in-partnership-with
https://www.nasdaq.com/press-release/biodesix-announces-commercial-availability-of-sars-cov-2-neutralization-antibody-test
https://www.nasdaq.com/press-release/biodesix-partners-with-datavant-to-enhance-value-of-lung-cancer-databank-2021-06-04-0
https://www.nasdaq.com/press-release/biodesix-partners-with-datavant-to-enhance-value-of-lung-cancer-databank-2021-06-04
https://www.nasdaq.com/press-release/first-patient-enrolled-in-biodesix-and-addario-lung-cancer-medical-institute-study
https://www.nasdaq.com/press-release/biodesix-to-present-at-the-william-blair-41st-annual-growth-stock-conference-2021-05
https://www.nasdaq.com/press-release/biodesix-announces-first-quarter-2021-results-2021-05-13
https://www.nasdaq.com/press-release/biodesix-announces-intent-to-launch-liquid-biopsy-next-generation-sequencing-test
https://www.nasdaq.com/press-release/biodesix-announces-presentation-on-sars-cov-2-neutralizing-antibody-testing-for
https://www.nasdaq.com/press-release/biodesix-to-report-first-quarter-2021-financial-results-on-may-11-2021-2021-04-26
https://www.nasdaq.com/press-release/biodesix-announces-presentation-on-use-of-biomarker-based-risk-assessment-to-inform
https://www.nasdaq.com/press-release/biodesix-releases-new-data-at-aacr-on-proteomic-profiling-to-help-guide-physician
https://www.nasdaq.com/press-release/biodesix-announces-issuance-of-two-u.s.-patents-expands-coverage-of-diagnostic
https://www.nasdaq.com/press-release/biodesix-announces-closing-of-new-%2430-million-term-loan-2021-03-23
https://www.nasdaq.com/press-release/biodesix-announces-fourth-quarter-and-full-year-2020-results-2021-03-16
https://www.nasdaq.com/press-release/biodesix-to-report-fourth-quarter-and-fiscal-2020-financial-results-on-march-16-2021
https://www.nasdaq.com/press-release/biodesix-ceo-scott-hutton-selected-as-one-of-top-25-biotech-ceos-of-2021-2021-02-25
https://www.nasdaq.com/press-release/biodesix-partners-with-chicago-public-schools-for-covid-19-testing-to-safely-reopen
https://www.nasdaq.com/press-release/biodesix-to-participate-in-two-february-conferences-2021-02-12
https://www.nasdaq.com/press-release/biodesix-publishes-data-on-new-covid-19-artificial-intelligence-ai-based-algorithm
https://www.nasdaq.com/press-release/scott-hutton-of-biodesix-selected-as-usa-chief-executive-officer-of-the-year-by-ceo
https://www.nasdaq.com/press-release/biodesix-to-showcase-new-data-on-patient-immune-profiling-from-multiple-studies-at
https://www.nasdaq.com/press-release/hibercell-and-biodesix-initiate-broad-collaboration-for-companion-diagnostic
https://www.nasdaq.com/press-release/hibercell-and-biodesix-initiate-broad-collaboration-for-companion-diagnostic-0
https://www.nasdaq.com/press-release/biodesix-anticipates-strong-preliminary-fourth-quarter-2020-revenue-unaudited-2021-01
https://www.nasdaq.com/press-release/purdue-partners-with-colorado-company-to-offer-rapid-testing-for-students-ahead-of
https://www.nasdaq.com/press-release/biodesix-announces-hiring-of-ryan-siurek-as-chief-accounting-officer-2021-01-05
https://www.nasdaq.com/press-release/biodesix-initiates-biomarker-study-to-affirm-nodify-xl2r-tests-importance-in-clinical
https://www.nasdaq.com/press-release/biodesix-study-shows-proprietary-device-collects-separates-and-transports-blood-at
